Aquavit Receives FDA Clearance for Two INDs to Initiate Clinical Trials With Its Botulinum Toxin

/PRNewswire/ -- Aquavit Holdings (Aquavit), a biotechnology company focused on the development of botulinum toxin applications, announced today that it has...

Related Keywords

United States ,Churlsu Kwon ,Sobin Chang ,Institute For Botulinum Toxin Research ,Aquavit Holdings ,Prnewswire Aquavit Holdings ,Investigational New Drug ,Chief Executive Officer ,Botulinum Toxin Research ,Chief Medical Officer ,